68 active
/
184 total (since 2015)
7
Phase 1 Active
20 total
26
Phase 2 Active
69 total
15
Phase 3 Active
44 total
23
Phase 4 Active
63 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 5 4 0
Vanda Pharmaceuticals 4 2 0
Idorsia Pharmaceuticals Ltd. 1 7 0
Sequential Medicine Ltd 1 2 1
Merck 1 0 0
Apsen Farmaceutica S.A. 1 0 0
Proactive Life Inc 1 0 0
RDC Clinical Pty Ltd 1 0 0
Reconnect Labs 1 0 0
Avecho Biotechnology 1 0 0
Nyree Penn 1 0 0
Afasci Inc 1 0 0
Nanjing Chia-tai Tianqing Pharmaceutical 1 0 0
ProofPilot 1 0 0
Taisho Pharmaceutical Co., Ltd. 0 4 0
NCT06655883 RECRUITING
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Merck Sharp & Dohme LLC n=300
NCT06476392 ACTIVE NOT RECRUITING
Melatonin fOr CHronic bAck Pain (The MOCHA Trial)
Odense University Hospital n=220
NCT03668041 ACTIVE NOT RECRUITING
National Adaptive Trial for PTSD Related Insomnia
VA Office of Research and Development n=673
NCT04652882 RECRUITING
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Vanda Pharmaceuticals n=70
NCT06619912 RECRUITING
Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients
Xijing Hospital n=686
NCT06975514 RECRUITING
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. n=60
NCT05840822 RECRUITING
Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia
Avecho Biotechnology n=519
NCT06953869 RECRUITING
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Vanda Pharmaceuticals n=420
NCT06062953 RECRUITING
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
Lone Baandrup n=255
NCT06859190 RECRUITING
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Qinghai Red Cross Hospital n=60
NCT04050176 ACTIVE NOT RECRUITING
Use of Blinded Tapering for Hypnotic Discontinuation
National Jewish Health n=260
NCT06701396 RECRUITING
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Vanda Pharmaceuticals n=60
NCT06512363 NOT YET RECRUITING
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
Nanjing Chia-tai Tianqing Pharmaceutical n=280
NCT05525637 RECRUITING
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. n=1,041
NCT05361707 RECRUITING
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Vanda Pharmaceuticals n=100
NCT07028697 COMPLETED
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Nxera Pharma Korea Co., Ltd. n=164
NCT04759703 TERMINATED
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
Massachusetts General Hospital n=75
NCT05461352 COMPLETED
Long-Term Study of TS-142 in Patients with Insomnia
Taisho Pharmaceutical Co., Ltd. n=401
NCT05453136 COMPLETED
Phase III Study of TS-142 in Patients with Insomnia
Taisho Pharmaceutical Co., Ltd. n=1,155
NCT02783729 COMPLETED
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Eisai Inc. n=1,006
NCT06010693 COMPLETED
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
Jiangsu Simcere Pharmaceutical Co., Ltd. n=206
NCT03338764 WITHDRAWN
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
Sequential Medicine Ltd
NCT03534284 COMPLETED
Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
University of Washington n=126
NCT03771664 TERMINATED
A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
Biogen n=87
NCT03373201 COMPLETED
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Vanda Pharmaceuticals n=320
NCT03575104 COMPLETED
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Idorsia Pharmaceuticals Ltd. n=924
NCT03545191 COMPLETED
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
Idorsia Pharmaceuticals Ltd. n=930
NCT03679884 COMPLETED
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Idorsia Pharmaceuticals Ltd. n=804
NCT02333149 WITHDRAWN
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
University of Alberta
NCT02987985 COMPLETED
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
University of Saskatchewan n=50
NCT03478306 COMPLETED
Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
Glostrup University Hospital, Copenhagen n=31
NCT04009577 COMPLETED
A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia
Eisai Inc. n=53
NCT03075241 COMPLETED
Z-Drugs for Sleep Disorders in Alzheimer's Disease
Brasilia University Hospital n=62
NCT02952820 COMPLETED
Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)
Eisai Inc. n=971
NCT03331042 COMPLETED
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
Sequential Medicine Ltd n=85
NCT02757066 COMPLETED
Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders
Nobelpharma n=196
NCT02757079 COMPLETED
Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders
Nobelpharma n=99
NCT02108353 COMPLETED
Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers
Universitätsklinikum Hamburg-Eppendorf n=46
NCT02232256 WITHDRAWN
The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain
9305-9954 Quebec Inc
Data: ClinicalTrials.gov